Pathogenesis and approaches to therapy of membranoproliferative glomerulonephritis.
D000818:Animals; D001485:Basement Membrane / Q000473:pathology; D002196:Capillaries / Q000473:pathology; D002199:Capillary Permeability; D003176:Complement C3 / Q000032:analysis; D004727:Endothelium / Q000473:pathology; D005919:Glomerular Filtration Rate; D005921:Glomerulonephritis / Q000209:etiology* / Q000276:immunology / Q000628:therapy; D006801:Humans; D007105:Immune Complex Diseases / Q000473:pathology; D007136:Immunoglobulins / Q000032:analysis; D007165:Immunosuppression Therapy; D007678:Kidney Glomerulus / Q000473:pathology; D008060:Lipodystrophy / Q000150:complications; D011414:Properdin / Q000032:analysis; D013290:Streptococcal Infections / Q000150:complications
D003176:Complement C3; D007136:Immunoglobulins; D011414:Properdin